JP2011502994A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502994A5
JP2011502994A5 JP2010532265A JP2010532265A JP2011502994A5 JP 2011502994 A5 JP2011502994 A5 JP 2011502994A5 JP 2010532265 A JP2010532265 A JP 2010532265A JP 2010532265 A JP2010532265 A JP 2010532265A JP 2011502994 A5 JP2011502994 A5 JP 2011502994A5
Authority
JP
Japan
Prior art keywords
independently
group
halogen
optionally
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010532265A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502994A (ja
JP5444239B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/081933 external-priority patent/WO2009073300A1/en
Publication of JP2011502994A publication Critical patent/JP2011502994A/ja
Publication of JP2011502994A5 publication Critical patent/JP2011502994A5/ja
Application granted granted Critical
Publication of JP5444239B2 publication Critical patent/JP5444239B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010532265A 2007-11-02 2008-10-31 タンパク質キナーゼC−θとしての[1H−ピラゾロ[3,4−B]ピリジン−4−イル]−フェニレンまたは−ピリジン−2−イル誘導体 Expired - Fee Related JP5444239B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US98487507P 2007-11-02 2007-11-02
US60/984,875 2007-11-02
US4457508P 2008-04-14 2008-04-14
US61/044,575 2008-04-14
US10080808P 2008-09-29 2008-09-29
US61/100,808 2008-09-29
PCT/US2008/081933 WO2009073300A1 (en) 2007-11-02 2008-10-31 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta

Publications (3)

Publication Number Publication Date
JP2011502994A JP2011502994A (ja) 2011-01-27
JP2011502994A5 true JP2011502994A5 (2) 2012-12-13
JP5444239B2 JP5444239B2 (ja) 2014-03-19

Family

ID=40220120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010532265A Expired - Fee Related JP5444239B2 (ja) 2007-11-02 2008-10-31 タンパク質キナーゼC−θとしての[1H−ピラゾロ[3,4−B]ピリジン−4−イル]−フェニレンまたは−ピリジン−2−イル誘導体

Country Status (16)

Country Link
US (2) US8173635B2 (2)
EP (1) EP2215089B1 (2)
JP (1) JP5444239B2 (2)
KR (1) KR20100093552A (2)
CN (1) CN101903384A (2)
AR (1) AR069174A1 (2)
AU (1) AU2008331733A1 (2)
CA (1) CA2704266A1 (2)
CL (1) CL2008003280A1 (2)
ES (1) ES2389992T3 (2)
IL (1) IL205458A0 (2)
MX (1) MX2010004819A (2)
NZ (1) NZ585063A (2)
TW (1) TW200924762A (2)
WO (1) WO2009073300A1 (2)
ZA (1) ZA201003050B (2)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3456189B2 (ja) 2000-03-31 2003-10-14 日本電気株式会社 移動通信システム
UA95940C2 (uk) 2006-01-17 2011-09-26 Вертекс Фармасьютикалс Інкорпорейтед Азаіндоли як інгібітори кіназ януса
CN101678022A (zh) 2006-12-21 2010-03-24 弗特克斯药品有限公司 可用作蛋白激酶抑制剂的5-氰基-4-(吡咯并[2,3b]吡啶-3-基)嘧啶衍生物
TW200924762A (en) 2007-11-02 2009-06-16 Vertex Pharma Kinase inhibitors
JP2011513483A (ja) * 2008-03-10 2011-04-28 バーテックス ファーマシューティカルズ インコーポレイテッド タンパク質キナーゼの阻害剤として有用なピリミジンおよびピリジン
US8569337B2 (en) 2008-07-23 2013-10-29 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
CA2732765A1 (en) 2008-08-06 2010-02-11 Vertex Pharmaceuticals Incorporated Aminopyridine kinase inhibitors
SG174214A1 (en) 2009-03-25 2011-10-28 Abbott Lab Antiviral compounds and uses thereof
CA2760705A1 (en) * 2009-05-06 2010-11-11 Vertex Pharmaceuticals Incorporated Pyrazolopyridines
LT3141252T (lt) 2009-06-17 2018-11-12 Vertex Pharmaceuticals Inc. Gripo virusų replikacijos inhibitoriai
EP2582702A1 (en) 2010-01-27 2013-04-24 Vertex Pharmaceuticals Incorporated Pyrazolopyrimidine kinase inhibitors
JP5769733B2 (ja) * 2010-01-27 2015-08-26 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated ピラゾロピリジンキナーゼ阻害剤
MX2012008642A (es) * 2010-01-27 2012-11-23 Vertex Pharma Inhibidores de cinasas de pirazolopiridinas.
CA2787079A1 (en) 2010-01-27 2011-08-04 Vertex Pharmaceuticals Incorporated Pyrazolopyrazine kinase inhibitors
CN102471342A (zh) * 2010-05-05 2012-05-23 沃泰克斯药物股份有限公司 用作PKC-θ抑制剂的4取代的吡唑并吡啶类
RU2013132681A (ru) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
CN103562205A (zh) 2010-12-16 2014-02-05 沃泰克斯药物股份有限公司 流感病毒复制的抑制剂
CA2822059A1 (en) 2010-12-16 2012-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP2858984A1 (en) 2012-06-08 2015-04-15 Vertex Pharmaceuticals Inc. Inhibitors of influenza viruses replication
US9523045B2 (en) 2013-01-30 2016-12-20 Ecolab Usa Inc. Hydrogen sulfide scavengers
LT3068776T (lt) 2013-11-13 2019-08-12 Vertex Pharmaceuticals Incorporated Gripo virusų replikacijos inhibitoriai
JP6618901B2 (ja) 2013-11-13 2019-12-11 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated インフルエンザウイルスの複製の阻害剤を調製する方法
US9556126B2 (en) 2013-12-20 2017-01-31 Signal Pharmaceuticals, Llc Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
TW201613919A (en) 2014-07-02 2016-04-16 Pharmacyclics Llc Inhibitors of Bruton's tyrosine kinase
EP3197450A1 (en) 2014-09-22 2017-08-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of fibrosis
AU2016250539B2 (en) 2015-04-22 2020-06-11 Championx Usa Inc. Development of a novel high temperature stable scavenger for removal of hydrogen sulfide
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
EP3294735B8 (en) 2015-05-13 2022-01-05 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
WO2017044248A1 (en) 2015-09-08 2017-03-16 Ecolab Usa Inc. Hydrogen sulfide scavengers
US10407626B2 (en) 2015-09-08 2019-09-10 Ecolab Usa Inc. Hydrocarbon soluble/dispersible hemiformals as hydrogen sulfide scavengers
EP3491106B1 (en) 2016-07-29 2020-07-15 Ecolab Usa Inc. Antifouling and hydrogen sulfide scavenging compositions
CR20190119A (es) * 2016-09-09 2019-06-03 Novartis Ag Compuestos y composiciones como inhibidores de los receptores endosomales tipo peaje
US10538710B2 (en) 2017-07-13 2020-01-21 Ecolab Usa Inc. Hydrogen sulfide scavengers
EP3914676A1 (en) 2019-01-23 2021-12-01 ChampionX USA Inc. Complete removal of solids during hydrogen sulfide scavenging operations using a scavenger and a michael acceptor
CA3136348A1 (en) * 2019-04-09 2020-10-15 Nurix Therapeutics, Inc. 3-substituted piperidine compounds for cbl-b inhibition, and use of a cbl-b inhibitor in combination with a cancer vaccine and/or oncolytic virus
CN111529533B (zh) * 2020-06-05 2021-06-11 南华大学附属第一医院 溴结构域蛋白4抑制剂jq1或其衍生物在制备治疗脓毒症肠屏障损伤药物中的应用
WO2022234298A1 (en) * 2021-05-06 2022-11-10 Exscientia Ai Limited Pkc-theta modulators
PE20250019A1 (es) * 2021-05-06 2025-01-07 Exscientia Ai Ltd MODULADORES DE PKC-theta

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2080531A (en) * 1936-01-08 1937-05-18 United Shoe Machinery Corp Manufacture of shoes
US3314941A (en) * 1964-06-23 1967-04-18 American Cyanamid Co Novel substituted pyridodiazepins
GB1159487A (en) 1968-04-04 1969-07-23 Standard Telephones Cables Ltd Capacitors
US4988705A (en) * 1985-06-13 1991-01-29 Schering Corporation Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
JP2890448B2 (ja) 1988-04-26 1999-05-17 日産化学工業株式会社 ピラゾロピリジン系メバロノラクトン類
US5100768A (en) * 1989-05-09 1992-03-31 Kabushiki Kaisha Toshiba Photosensitive composition
JPH03206450A (ja) * 1990-01-09 1991-09-09 Fuji Photo Film Co Ltd 新規な色素形成カプラー及びそれを用いたハロゲン化銀カラー写真感光材料及びその処理方法
JPH03271289A (ja) 1990-03-16 1991-12-03 Nissan Chem Ind Ltd ピラゾロピリジン誘導体の製造法及びジヒドロピラゾロピリジン誘導体
US5338740A (en) * 1993-07-13 1994-08-16 Pfizer Inc. Angiotensin II receptor antagonists
US5646330A (en) * 1995-02-17 1997-07-08 Ciba-Geigy Corporation Production of enantiomerically enriched ortho-substituted α,α-diaromatic methanols
US6194581B1 (en) * 1995-04-07 2001-02-27 Merck & Co., Inc. Substituted pyridines useful as modulators of acetylcholine receptors
SE9704544D0 (sv) * 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
US6452008B2 (en) * 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
GB9908410D0 (en) * 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
PE20010306A1 (es) 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
AR029289A1 (es) * 2000-07-05 2003-06-18 Ishihara Sangyo Kaisha Derivado de benzoilpiridina o su sal, fungicida que lo contiene como un ingrediente activo, su proceso de produccion e intermediario para producirlo
JP2002020386A (ja) 2000-07-07 2002-01-23 Ono Pharmaceut Co Ltd ピラゾロピリジン誘導体
DE10035908A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
WO2002020500A2 (en) * 2000-09-01 2002-03-14 Icos Corporation Materials and methods to potentiate cancer treatment
GB0128287D0 (en) 2001-11-26 2002-01-16 Smithkline Beecham Plc Novel method and compounds
JP2005516927A (ja) * 2001-12-13 2005-06-09 アボット・ラボラトリーズ 癌治療用のキナーゼ阻害剤としての3−(フェニル−アルコキシ)−5−(フェニル)−ピリジン誘導体および関連化合物
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
DE10222550A1 (de) * 2002-05-17 2003-11-27 Bayer Ag Substituierte Benzyl-pyrazolopyridine
JPWO2004002531A1 (ja) * 2002-06-26 2005-10-27 小野薬品工業株式会社 血管の収縮または拡張による疾患治療剤
EP1545515A1 (en) 2002-08-12 2005-06-29 Sugen, Inc. 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
US20040242613A1 (en) * 2003-01-30 2004-12-02 Boehringer Ingelheim Pharmaceuticals, Inc. Pyrimidine derivatives useful as inhibitors of PKC-theta
CA2518398A1 (en) 2003-03-10 2004-09-23 Schering Corporation Heterocyclic kinase inhibitors: methods of use and synthesis
US20050203067A1 (en) * 2003-05-12 2005-09-15 Hresko Michelle C. Pesticidal compositions and methods
EP1660087A2 (en) * 2003-07-22 2006-05-31 Janssen Pharmaceutica N.V. Quinolinone derivatives as inhibitors of c-fms kinase
WO2005044181A2 (en) 2003-09-09 2005-05-19 Temple University-Of The Commonwealth System Of Higher Education Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
JP4805166B2 (ja) * 2003-12-22 2011-11-02 バジリア ファルマスーチカ アーゲー アロイルフランおよびアロイルチオフェン
UY29177A1 (es) * 2004-10-25 2006-05-31 Astex Therapeutics Ltd Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
ATE554087T1 (de) * 2004-10-29 2012-05-15 Abbott Lab Neue kinaseinhibitoren
WO2006050076A1 (en) 2004-10-29 2006-05-11 Janssen Pharmaceutica, N.V. Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
EP1812450A2 (en) 2004-11-10 2007-08-01 Eli Lilly And Company Tgf-beta inhibitors
DE102004061288A1 (de) * 2004-12-14 2006-06-29 Schering Ag 3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel
PE20061119A1 (es) * 2005-01-19 2006-11-27 Aventis Pharma Sa PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
WO2006101456A1 (en) 2005-03-21 2006-09-28 S*Bio Pte Ltd Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors
RU2387653C2 (ru) * 2005-05-16 2010-04-27 Айрм Ллк Соединения и композиции в качестве ингибиторов протеинкиназ
US7846941B2 (en) 2005-05-17 2010-12-07 Plexxikon, Inc. Compounds modulating c-kit and c-fms activity and uses therefor
DE102005035417A1 (de) 2005-07-28 2007-02-01 Robert Bosch Gmbh Entfernungsmessgerät und Verfahren zum Befestigen einer elektrooptischen Einheit an einer Leiterträgereinheit
US7547782B2 (en) 2005-09-30 2009-06-16 Bristol-Myers Squibb Company Met kinase inhibitors
DE102005048897A1 (de) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
WO2007076423A2 (en) 2005-12-22 2007-07-05 Smithkline Beecham Corporation INHIBITORS OF Akt ACTIVITY
WO2007084667A2 (en) 2006-01-19 2007-07-26 Osi Pharmaceutical, Inc. Fused heterobicyclic kinase inhibitors
DK3421471T3 (da) * 2006-04-25 2021-06-14 Astex Therapeutics Ltd Purin- og deazapurinderivater som farmaceutiske forbindelser
TW200815438A (en) 2006-06-13 2008-04-01 Bayer Schering Pharma Ag Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
MX337906B (es) 2006-10-19 2016-03-28 Signal Pharm Llc Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
JP2008132121A (ja) * 2006-11-28 2008-06-12 Sanshin Kinzoku Kogyo Kk 移動ラック装置
EP2118088B1 (en) 2006-12-20 2012-05-30 Amgen Inc. Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
WO2008132121A1 (en) * 2007-04-26 2008-11-06 Glaxo Group Limited Lh-indazole-3-amine compounds as ikk1 inhibitors
TW200924762A (en) 2007-11-02 2009-06-16 Vertex Pharma Kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2011502994A5 (2)
JP6982376B2 (ja) Rorガンマ調節物質としての置換型テトラヒドロキノリン化合物
JP2021073298A (ja) ピリミジニルチロシンキナーゼ阻害剤
JP2015502387A5 (2)
JP2013539762A (ja) フロ[3,2−d]ピリミジン化合物
JP2008533201A (ja) イミダゾピリダジン化合物
KR20150042830A (ko) 인간 면역결핍 바이러스 복제의 억제제
JP5600311B2 (ja) Hivインテグラーゼ阻害剤
CN102924458A (zh) 6,6-双环取代的杂双环蛋白激酶抑制剂
SG181147A1 (en) Novel tricyclic compounds
Sun et al. Pyridine-phosphinimine ligand-accelerated Cu (i)-catalyzed azide–alkyne cycloaddition for preparation of 1-(pyridin-2-yl)-1, 2, 3-triazole derivatives
JP2016516706A5 (2)
TW201605814A (zh) 用於合成經保護之n-烷基三唑甲醛的三唑中間體
JP7045528B2 (ja) Hivに感染した細胞に対する選択的細胞毒性薬としてのピリミドン誘導体
JP2015525776A5 (2)
Goryaeva et al. The reactions of 2-ethoxymethylidene-3-oxo esters and their analogues with 5-aminotetrazole as a way to novel azaheterocycles
CN105189510A (zh) 人免疫缺陷病毒复制的抑制剂
AU2022283404A1 (en) Quinolinamine compound, preparation method therefor and application thereof in pharmaceuticals
WO2016088094A1 (en) Process for the preparation of baricitinib and an intermediate thereof
Yu et al. Facile, eco-friendly, catalyst-free synthesis of polyfunctionalized 2-aminopyrroles
CA2755061A1 (en) Pyrimidine derivatives as mtor inhibitors
KR102295416B1 (ko) 1-(피페라진-1-일)-2-([1,2,4]트리아졸-1-일)-에타논 유도체
Sugi et al. Environmentally friendly TPDS-mediated free radical ring expansion of α-haloalkyl cyclic β-keto esters
Beaudoin et al. Efficient, scalable syntheses of important intermediates in tribenzotriquinacene chemistry
WO2020054657A1 (ja) 新規ヘテロ芳香族アミド誘導体及びそれを含有する医薬